👀 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

PRECIOUS-Gold rises as soft U.S. jobs data bolsters stimulus bets

Published 07/12/2020, 02:45 pm
Updated 07/12/2020, 06:48 pm
XAU/USD
-
XAG/USD
-
GC
-
SI
-
PA
-
PL
-

(Adds comment, updates prices)

* Bipartisan stimulus deal suggests more compromise ahead- analyst

* Britain to begin Pfizer/BioNTech vaccine rollout this week

* Gold has resistance at $1,850 an ounce - analyst

* Interactive graphic tracking global spread of coronavirus: open

* https://tmsnrt.rs/3aIRuz7 in an external browser

By Nakul Iyer

Dec 7 (Reuters) - Gold ticked higher on Monday, as the metal drew support from grim U.S. jobs data that fuelled optimism over a U.S. stimulus deal, although gains were capped by coronavirus vaccine rollouts.

Spot gold prices XAU= rose 0.2% to $1,840.65 per ounce by 0725 GMT, while U.S. gold futures GCv1 were up 0.2% at $1,843.90.

"Softer jobs growth and tighter social mobility restrictions ostensibly lower the hurdle for a policy response from (U.S.) Congress," said Stephen Innes, chief global market strategist at financial services firm Axi.

Data on Friday showed the U.S. economy added the fewest jobs in six months in November. over a fresh pandemic relief package gathered momentum on Friday, as bipartisan U.S. lawmakers worked to put the finishing touches on a new $908 billion bill. the gold market might be disappointed with the size of the package, markets will likely take support from the bipartisan nature of the deal that suggests further compromise in the U.S Congress ahead, Innes said.

Gold is seen as a hedge against inflation that could result from large stimulus.

Given increased inflation expectations, rising coronavirus cases, continued dollar weakness and a stalling U.S. labour market, gold could test $1,900 in December, said Kunal Shah, head of research at Nirmal Bang Commodities in Mumbai, India.

However, gold's gains were capped as Britain prepared to become the first country to roll out the Pfizer/BioNTech COVID-19 vaccine this week. has resistance at $1,850 an ounce, with a close above that pivot level setting the scene for a test of the resistance line at $1,920 an ounce, Jeffrey Halley, a senior market analyst at OANDA, said in note.

Silver XAG= fell 0.4% to $24.06 per ounce and platinum XPT= dropped 1.5% to $1,039.00, while palladium XPD= gained 0.8% to $2,363.00.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.